norfloxacin has been researched along with Keratitis in 5 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Keratitis: Inflammation of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present three cases of norfloxacin deposits after treatment of bacterial keratitis." | 7.69 | Deposits of topical norfloxacin in the treatment of bacterial keratitis. ( Benitez del Castillo, JM; Castillo, A; Diaz-Valle, D; Garcia-Sanchez, J; Sayagues, O; Toledano, N, 1997) |
| "We present three cases of norfloxacin deposits after treatment of bacterial keratitis." | 3.69 | Deposits of topical norfloxacin in the treatment of bacterial keratitis. ( Benitez del Castillo, JM; Castillo, A; Diaz-Valle, D; Garcia-Sanchez, J; Sayagues, O; Toledano, N, 1997) |
| "Ciprofloxacin was significantly more effective than norfloxacin in reducing the number of bacteria per cornea (P less than 0." | 1.28 | Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. ( Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ; Reidy, JJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, S | 1 |
| Koh, JJ | 1 |
| Aung, TT | 1 |
| Sin, WLW | 1 |
| Lim, F | 1 |
| Wang, L | 1 |
| Lakshminarayanan, R | 1 |
| Zhou, L | 1 |
| Tan, DTH | 1 |
| Cao, D | 1 |
| Beuerman, RW | 1 |
| Ren, L | 1 |
| Liu, S | 1 |
| Diamond, JP | 1 |
| White, L | 1 |
| Leeming, JP | 1 |
| Bing Hoh, H | 1 |
| Easty, DL | 1 |
| Castillo, A | 1 |
| Benitez del Castillo, JM | 1 |
| Toledano, N | 1 |
| Diaz-Valle, D | 1 |
| Sayagues, O | 1 |
| Garcia-Sanchez, J | 1 |
| Reidy, JJ | 2 |
| Hobden, JA | 2 |
| Hill, JM | 2 |
| Forman, K | 1 |
| O'Callaghan, RJ | 2 |
| Insler, MS | 1 |
5 other studies available for norfloxacin and Keratitis
| Article | Year |
|---|---|
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; C | 2017 |
Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromatography, High Pressure Liquid; Ciprofloxac | 1995 |
Deposits of topical norfloxacin in the treatment of bacterial keratitis.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Chemical Precipitation; Cornea; Corneal Diseases; Cr | 1997 |
The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Ciprofloxacin; Colony Count, Microbial; Keratitis; Norfloxacin; Ps | 1991 |
Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis.
Topics: Animals; Ciprofloxacin; Collagen; Colony Count, Microbial; Cornea; Drug Resistance, Microbial; Eye I | 1990 |